Overview
The Library has signed up to a Read & Publish agreement with ACM Open. The deal began on the 1st January 2023 and will end on the 31st December 2025.
Publish
Unlimited open access for QUB corresponding authors publishing research articles and conference proceedings in any ACM Open journal.
Overview
The Library has signed up to a Read & Publish agreement with the American Chemical Society. The deal began on the 1st January 2022 and will end on the 31 December 2024.
Publish
Unlimited open access publishing for all research articles in all ACS journals, including ACS Omega, JACS Au, the ACS Au collection, and all ACS hybrid journals. (Includes both Hybrid and Fully OA titles)
QUB corresponding authors only.
Overview
The Library has signed up to a Read & Publish agreement with the American Physical Society. The deal began on the 1st January 2024 and will end on the 31st December 2025.
Read
Access to all subscription content.
Publish
Unlimited open access for QUB corresponding authors publishing research articles in hybrid journals.
*Reviews of Modern Physics (RMP) - is a dedicated and commissioned reviews journal and does not currently offer an open access option
Overview
The Library has signed up to a Read & Publish agreement with the American Physiological Society. The deal began on the 1st January 2021 and will end on the 31 December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in the publishers' 12 hybrid journal titles.
Full OA titles not included in the deal.
Overview
The Library has signed up to a one year read & publish pilot with the American Psychological Association. The deal began on the 1st August 2023 and will end on the 31st July 2024.
Publish
This one-year pilot allows capped OA publishing in 87 hybrid journals in the PsycArticles portfolio, plus an additional 15 hybrid titles in the Hogrefe collection of journals. Research and Review articles only.
Fully OA journals are not included in the deal, however Queen’s corresponding authors are entitled to a 25% discount on the APC in three fully OA Hogrefe journals.
All authors are entitled to zero embargo Green OA with APA Copyright as per APA’s standard policy: https://www.apa.org/pubs/journals/resources/open-access
Overview
The Library has signed up to a Read & Publish agreement with Bioscientifica. The deal began on the 1st January 2021 and will end on the 31 December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in Bioscientifica's four hybrid journals.
Overview
The Library has signed up to a Read & Publish agreement with BMJ. The deal began on the 1st January 2022 and will end on the 31 December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in BMJ's hybrid journal titles.
Original research articles only.
Overview
The Library has signed up to a Read & Publish agreement with Brill. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Uncapped open access publishing for QUB corresponding authors in all of Brill’s journals. Includes research and review articles, as well as conference papers.
Overview
The Library has signed up to a Read & Publish agreement with Bristol University Press. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in BUP's hybrid journals. (Original research articles only).
Overview
The Library has signed up to a Read & Publish agreement with Cambridge University Press. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Queen’s corresponding authors can publish articles with immediate open access in any CUP Gold or Hybrid journal: click here for a list of Cambridge journals covered by the agreement.
Open Access publishing will be unlimited for 2024.
Cambridge Prisms and Research Directions
Cambridge Prisms and Research Directions are two new series of OA journals designed to reflect the research process, address real-world challenges, and build connections across disciplines. Both series operate open peer review, have open data mandates and follow open standards.
This is a 1 year pilot that runs until the 31st December 2024. Unlimited publishing for Queen's corresponding authors.
Overview
The Library has signed up to a Read & Publish agreement with Cold Spring Harbor Laboratory Press. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Publish
Unlimited open access publishing of research articles for QUB corresponding authors in four research titles: Genes & Development, Genome Research, RNA, and Learning & Memory.
Overview
The Library has signed up to a three year Read & Publish agreement with The Company of Biologists. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in 3 hybrid journals: Development, Journal of Cell Science, The Journal of Experimental Biology + two fully OA journals, Disease Models & mechanisms, Biology Open.
Overview
The Library has signed up to a Read & Publish agreement with De Gruyter. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Open Access publishing for QUB corresponding authors in De Gruyter's Hybrid & Gold OA titles.
Overview
The Library has signed up to a Read & Publish agreement with Elsevier. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors publishing in Elsevier's Core-hybrid, Cell Press, and the Lancet titles (hybrid only).
Discover which Elsevier journals are participating in the agreement here.
Authors publishing in Elsevier's fully open access journals will have to pay an article processing charge (APC). Queen's corresponding authors are entitled to a 15% discount on the APC. Please visit Queen's Gold Open Access page to see if your research funder has provided Queen's with funds to pay your APC.
Overview
The Library has renewed its Read & Publish deal with the European Respiratory Society. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in the European Respiratory Journal, ERJ Open Research, & European Respiratory Review.
Overview
The Library has signed up to a Read & Publish agreement with Future Science Group. The deal began on the 1st January 2021 and will end on the 31st December 2025.
Publish
Unlimited open access publishing for QUB corresponding authors in all FSG journals. All article types (excluding Drug Evaluation articles and content/research sponsored or funded by pharma/biotech).
Overview
The Library has signed up to a Read & Publish agreement with the Geological Society. The deal began on the 1st January 2021 and will end on the 31st December 2025.
Publish
Unlimited open access publishing for QUB corresponding authors in 6 hybrid journals and 3 hybrid book series.
Overview
The Library has signed up to a Read & Publish agreement with the Institute of Physics (IOP). The deal was renewed on the 1st January 2024 and will end on the 31st December 2025.
Publish criteria
Eligible Authors: Queen's corresponding authors.
Journals covered: Any IOP hybrid journal & fully OA title with the exception of journals published on behalf of the American Astronomical Society.
Article type covered: All primary research articles, including research papers, special issue articles, letters and review articles* are eligible for inclusion under the terms of the license.
(*Reports on Progress in Physics, a new addition to our hybrid publishing list, will only include primary research articles within the publishing element of the license.)
Article allocation: Unlimited
Please enter "Institute of Physics" in the search box below to discover eligible titles.
Overview
The Library has signed up to a Read & Publish agreement with Karger. The deal began on the 1st January 2021 and will end on the 31st December 2026.
Publish
Unlimited open access publishing for QUB corresponding authors in any hybrid or fully OA journal. All article types covered.
Overview
The Library has signed up to a Read & Publish agreement with the Microbiology Society. The deal began on the 1st January 2020 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors.
Overview
The Library has signed up to a Read & Publish agreement with Optica Publishing Group. This deal began on the 1st January 2022 and will end on the 31st December 2024.
Publish
Queen’s corresponding authors can publish research & review articles with immediate open access in Optica journals (excludes Optics and Photonics News, and both partnered and legacy journals).
Open Access publishing will be unlimited for 2022
Overview
The Library has signed up to a Read & Publish agreement with the Oxford University Press. The deal was renewed on the 1st January 2024 and will end on the 31st December 2025.
Publish
Eligible authors: Queen's corresponding authors only
Type of publications covered: Hybrid & Fully OA journals
Article types covered: Research articles, review articles, brief reports and case reports. Article-commentary types are not eligible.
Article allocation: Unlimited publishing
Overview
The Library has signed up to a Read & Publish agreement with PLOS. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in all PLOS journals.
Overview
The Library has signed up to a Read & Publish agreement with Portland Press. The deal began on the 1st January 2021 and will end on the 31st December 2025.
Publish
Unlimited open access publishing for QUB corresponding authors in all 7 Portland Press journals.
Overview
The Library has signed up to a Read & Publish agreement with the Radiological Society of North America. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in Radiology.
Overview
The Library has signed up to a Read & Publish agreement with Rockefeller University Press. The deal began in March 2020 and will end on the 31st December 2025.
Publish
Unlimited open access publishing for QUB corresponding authors in RUP journals.
Overview
The Library has signed up to a Read & Publish agreement with the Royal College of General Practitioners. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in the British Journal of General Practice and BJGP Open.
Research articles only.
Overview
The Library has signed up to a Read & Publish agreement with the Royal Irish Academy. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in the publishers 6 subscription journals.
Overview
The Library has signed up to a Read & Publish agreement with the Royal Society. The deal began on the 1st January 2021 and will end on the 31st December 2024.
Publish
Unlimited open access for QUB corresponding authors publishing in all journals.
Overview
The Library has signed up to a Read & Publish agreement with the Royal Society Of Chemistry. The deal began on the 1st January 2022 and will end on the 31st December 2024.
Publish
OA article allocation - not unlimited open access publishing.
Only available to QUB corresponding authors publishing in a RSC Hybrid journal.
All peer reviewed article types are covered in this agreement which fall into three main categories: full papers, communications, and reviews.
Overview
The Library has signed up to a Read & Publish agreement with SAGE. The deal began on the 1st January 2023 and will end on the 31st December 2024.
Publish
Unlimited open access publishing for QUB corresponding authors in SAGE hybrid journals only. Excludes some article types, including, book reviews, and commercially sponsored articles.
Queen's corresponding authors will receive a 20% discount on APCs for fully Gold OA journals
Overview
The Library has signed up to a Read & Publish agreement with Springer Nature. The deal began on the 1st January 2023 and will end on the 31st December 2025.
The deal brings together Springer, Palgrave Macmillan, and Nature Research journals into one Read and Publish agreement.
Springer
Unlimited OA publishing for QUB corresponding authors in 2051 Springer, Academic and Palgrave Macmillan journals.
Nature Journals (Hybrid)
Open Access publishing for QUB corresponding authors is included in Nature Research journals. A consortium level cap is applicable.
Overview
The Library has signed up to a Read & Publish agreement with Taylor & Francis. The deal was renewed on the 1st January 2024 and will end on the 31st December 2025.
Publish
Eligible authors: Queen's corresponding authors only
Type of publications covered: Hybrid (Open Select), Fully OA/F1000 Research, Routledge Open Research.
Article types covered: Research articles only. For F1000 Research and Routledge Open Research the following are covered: including but not limited to Research Articles, Method Articles, Antibody Validation Articles, Reviews, Systematic Reviews, Clinical Practice Articles, Case Reports, Opinion Articles.
Article allocation: Consortium cap
Overview
The University Library is signed up to a read and publish deal with Wiley. This two-year agreement runs from January 2024 until December 2025.
Publish
Eligible authors: Queen's Corresponding Authors only
Type of publications covered: Hybrid and Fully OA journals
Article types covered: Research/Review/Case Reports
Licence: CC BY (default licence)
Overview
The Library has signed up to a Read & Publish agreement with Wolters Kluwer. The deal began on the 1st January 2022 and will end on the 31 December 2024.
Publish
Capped open access publishing for QUB corresponding authors in select hybrid journals.
Title exclusions:
Journal of the American College of Surgeons and titles within the JCO bundle are excluded from this Agreement.
Titles excluded: Journal of the American College of Surgeons, JCO Clinical Cancer Informatics, JCO Global Oncology, Journal of Clinical Oncology, JCO Oncology Practice, JCO Precision Oncology.